COPD (n=203) | |
---|---|
Male n (%) | 128 (63.1) |
Age (years) | 64.8 (7.5) |
BMI mean (SD) | 27.6 (5.2) |
Current smokers n (%) | 66 (32.5) |
Pack years median (IQR) | 41 (27 to 57) |
COPD duration in years (SD) | 7.5 (5.3) |
MOS mean (SD) | |
Sleep disturbance | 39.8 (25.2) |
Short of breath/headache | 26.2 (27.9) |
Sleep adequacy | 52.3 (27.4) |
Sleep problem index II | 41.7 (20.0) |
FACIT-F mean (SD) | 31.5 (13.1) |
HADS mean (SD) | |
Anxiety | 7.4 (4.5) |
% with HADS anxiety score >7 | 48.6 |
Depression | 5.9 (4.3) |
% with HADS depression score >7 | 35.4 |
SGRQ-C mean (SD) | |
Total | 51.9 (20.9) |
Symptom | 59.6 (19.5) |
Activity | 66.2 (27.7) |
Impact | 40.1 (22.8) |
mMRC dyspnoea scale n (%) | |
0 | 20 (9.9) |
1 | 64 (31.5) |
2 | 40 (19.7) |
3 | 56 (27.6) |
4 | 23 (11.3) |
Lung function | |
FEV1% predicted (%) | 56.6 (18.6) |
FEV/FVC (%) | 48.3 (13.4) |
GOLD n(%) | |
Grade 1 | 28 (13.8) |
FEV1% predicted (%) mean (SD) Min and Max | 87.7 (5.6) Min 80.0-Max 100.1) |
Grade 2 | 83 (40.9) |
FEV1% predicted (%) mean (SD) Min and Max | 64.0 (7.9) Min 51.1-Max 78.9) |
Grade 3 | 50 (24.6) |
FEV1% predicted (%) mean (SD) Min and Max | 43.3 (4.5) Min 34.2-Max 49.9) |
Grade 4 | 15 (7.4) |
FEV1% predicted (%) mean (SD) Min and Max | 23.9 (3.4) Min 21.9-Max 28.6) |
BMI, Body Mass Index; FACIT-F, Functional Assessment of Chronic Illness Therapy Fatigue Scale; GOLD, Global Initiative for Chronic Obstructive Lung Disease; HADS, Hospital Anxiety and Depression Scale; mMRC, modified Medical Research Council; MOS, Medical Outcomes Study; SGRQ-C, St George's Respiratory Questionnaire-C.